Octagon Capital Advisors »

Dbv Technologies Sa shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Dbv Technologies Sa (DBVT) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Dbv Technologies Sa

Tip: Access up to 7 years of quarterly data

All positions including Dbv Technologies Sa held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dbv Technologies Sa by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $10M 1.0M 10.00
2025-06-30 $9.3M 1.0M 9.15

More positions owned by Octagon Capital Advisors

Abivax Sa Sponsored Ads (ABVX)
Dianthus Therapeutics (DNTH)
Gossamer Bio (GOSS)
Cogent Biosciences (COGT)
Arrivent Biopharma (AVBP)
Ocular Therapeutix (OCUL)
Taysha Gene Therapies Com Shs (TSHA)
Merus N V (MRUS)
Cidara Therapeutics Com New (CDTX)
Trevi Therapeutics (TRVI)
Mind Medicine Mindmed Com New (MNMD)
Apellis Pharmaceuticals (APLS)
Kymera Therapeutics (KYMR)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Pharvaris N V (PHVS)

View all positions for Octagon Capital Advisors

Top funds holding Dbv Technologies Sa

Baker Bros. Advisors
Vivo Capital
MPM Oncology Impact Management
Octagon Capital Advisors
Yiheng Capital
Dr. Jeffrey R. Jay, M.D.
Adage Capital Partners GP
Millennium Management
Artisan Partners Limited Partnership
Nan Fung Trinity
Barclays
DLD Asset Management
Citadel Advisors
Morgan Stanley
Two Sigma Investments

View all funds holding Dbv Technologies Sa